SEC Form 4 · accession 0001123292-26-000995
Tevogen Inc. · TVGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan H. Saadi
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jul 10, 2026
Accepted (ET)
Jul 10, 2026 · 5:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001860871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 10, 2026 | A | 1,220,000 | $0.00 | A | 3,705,689 | D | |
| Common Stock | holding | — | — | — | 3,878 | I | By wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments commencing on July 10, 2033, provided that the reporting person remains in service with the Issuer at such dates.